Genetically-engineered mice are currently being developed for in vivo studies of brain development and a wide range of neurodevelopmental diseases. Indeed, defined mutant mice have been critical for identifying the affected genetic pathways and addressing the underlying cellular and molecular basis of developmental brain diseases. Lacking in these efforts have been effective in vivo imaging methods that can be used to study mouse models of neurodevelopmental disorders, especially during early postnatal stages when disease is first manifested, and the greatest changes in brain structure and function are likely to occur. A major challenge is therefore to develop and validate in vivo imaging techniques that can detect and monitor early changes in brain structure and function in the developing mouse brain. We have established quantitative, in vivo manganese (Mn)-enhanced MRI (MEMRI) approaches for analyzing the early postnatal mouse brain, showing that MEMRI provides an exquisitely sensitive method for revealing multiple nuclei and axonal tracts in the early postnatal mouse brain. Results from our laboratory and others have already proven the utility of MEMRI for assessing neural activity and connectivity. These new findings now point to the potential of MEMRI for in vivo detection and quantitative analysis of functional circuits in the developing mouse brain. We have also discovered that the Divalent Metal Transporter, DMT1 can be utilized as an effective reporter gene for MEMRI. We now propose to develop and test a combination of DMT1 expression with MEMRI to provide a precise in vivo approach to analyze functional connectivity in the mouse brain, starting from critical neonatal stages when the circuitry is first established. We will test this new imaging technology in mice with mutations in the mid-hindbrain (MHB) genes engrailed (En1 and En2) and Fgf17, which have morphological and functional cerebellum and midbrain phenotypes. Recent evidence also suggests that both En and Fgf17 mutant mice have defects in MHB circuitry. We will therefore use DMT1-MEMRI to study MHB circuitry in these mice during the critical postnatal period of brain development.
The specific aims of the project are: 1) Determine the normal stage-dependent MEMRI intensities in defined nuclei in wildtype (WT), En and Fgf17 mutant mice;2) Utilize DMT1 to genetically label defined nuclei for MEMRI analysis of midbrain and cerebellar circuits;and 3) Analyze differences in functional circuitry between WT, En and Fgf17 mouse mutants using DMT1-MEMRI. This research has high potential to establish an innovative, genetically-controlled form of MEMRI for in vivo analysis of circuits in the developing mouse brain, providing critical new tools for analyzing mouse models of a wide variety of neurodevelopmental disorders, including cerebellum hypoplasia syndromes (e.g., Joubert and Dandy-Walker syndromes), autism spectrum disorders, and schizophrenia.

Public Health Relevance

Mouse models are widely used for studying the molecular and cellular basis of many neurodevelopmental diseases, including autism. Lacking in this research are effective imaging methods to assess changes in brain function and connectivity in living mice, especially during early postnatal stages when disease is first manifested. In this project, we will develop novel magnetic resonance micro-imaging approaches to analyze neural circuits in the developing brains of a wide range of mouse models of neurodevelopmental disorders. !

National Institute of Health (NIH)
National Institute of Neurological Disorders and Stroke (NINDS)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-SBIB-Q (04))
Program Officer
Babcock, Debra J
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
New York University
Schools of Medicine
New York
United States
Zip Code
Bartelle, Benjamin B; Mana, Miyeko D; Suero-Abreu, Giselle A et al. (2014) Engineering an effective Mn-binding MRI reporter protein by subcellular targeting. Magn Reson Med :
Aristiz√°bal, Orlando; Mamou, Jonathan; Ketterling, Jeffrey A et al. (2013) High-throughput, high-frequency 3-D ultrasound for in utero analysis of embryonic mouse brain development. Ultrasound Med Biol 39:2321-32
Parasoglou, Prodromos; Berrios-Otero, Cesar A; Nieman, Brian J et al. (2013) High-resolution MRI of early-stage mouse embryos. NMR Biomed 26:224-31
Szulc, Kamila U; Nieman, Brian J; Houston, Edward J et al. (2013) MRI analysis of cerebellar and vestibular developmental phenotypes in Gbx2 conditional knockout mice. Magn Reson Med 70:1707-17
Berrios-Otero, Cesar A; Nieman, Brian J; Parasoglou, Prodromos et al. (2012) In utero phenotyping of mouse embryonic vasculature with MRI. Magn Reson Med 67:251-7
Yu, Xin; Nieman, Brian J; Sudarov, Anamaria et al. (2011) Morphological and functional midbrain phenotypes in Fibroblast Growth Factor 17 mutant mice detected by Mn-enhanced MRI. Neuroimage 56:1251-8
Cheng, Yulan; Sudarov, Anamaria; Szulc, Kamila U et al. (2010) The Engrailed homeobox genes determine the different foliation patterns in the vermis and hemispheres of the mammalian cerebellum. Development 137:519-29
Nieman, Brian J; Shyu, Jeffrey Y; Rodriguez, Joe J et al. (2010) In vivo MRI of neural cell migration dynamics in the mouse brain. Neuroimage 50:456-64
Nieman, Brian J; Turnbull, Daniel H (2010) Ultrasound and magnetic resonance microimaging of mouse development. Methods Enzymol 476:379-400
Mamou, Jonathan; Aristizabal, Orlando; Silverman, Ronald H et al. (2009) High-frequency chirp ultrasound imaging with an annular array for ophthalmologic and small-animal imaging. Ultrasound Med Biol 35:1198-208

Showing the most recent 10 out of 31 publications